Search

Pulse Biosciences Inc

Cerrado

SectorSanidad

48.88 -1.43

Resumen

Variación precio

24h

Actual

Mínimo

48.92

Máximo

50.38

Métricas clave

By Trading Economics

Ingresos

-6.1M

-25M

Ventas

33K

434K

BPA

-0.36

Margen de beneficios

-5,681.336

Empleados

116

EBITDA

-5.8M

-25M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

-10.25% downside

Dividendos

By Acuity

Próximas Ganancias

4 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

726M

3.3B

Apertura anterior

50.31

Cierre anterior

48.88

Noticias sobre sentimiento de mercado

By Acuity

61%

39%

299 / 340 Clasificación en Healthcare

Pulse Biosciences Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

24 ago 2026, 23:36 UTC

Pulse Biosciences Inc shares declined in after-market trading, following a brief peak, amid broader market concerns over geopolitical tensions affecting oil supply.

20 ago 2026, 20:06 UTC

Pulse Biosciences Inc is higher in Thursday's session, reflecting a broader market trend. The stock is trading above its 20-day moving average.

19 ago 2026, 19:16 UTC

Pulse Biosciences Inc is trading higher, maintaining gains since Tuesday's close. The stock remains above its 20-day moving average and near its one-month range high.

18 ago 2026, 19:56 UTC

News

Pulse Biosciences announced inducement grants for new employees, raising potential dilution concerns. Shares are trading lower during Tuesday's session, retracing from an early peak.

17 ago 2026, 22:36 UTC

Pulse Biosciences Inc shares are trading higher in after-market hours. The stock has gained significantly over the past month, reflecting broader market dynamics.

14 ago 2026, 19:11 UTC

Pulse Biosciences Inc shares are declining, breaking a trend of higher closes. The broader market reacts to an unexpected decline in U.S. retail sales.

13 ago 2026, 20:06 UTC

Pulse Biosciences Inc shares are higher, maintaining gains since Wednesday's close despite earlier intraday volatility and no specific news driving the movement.

12 ago 2026, 20:06 UTC

Pulse Biosciences Inc. shares are lower today, continuing a decline after an early peak. The asset remains above its 20-day moving average.

11 ago 2026, 23:01 UTC

Pulse Biosciences Inc shares are lower in after-market trading, reversing earlier gains despite being above its 20-day moving average. No specific news was identified.

10 ago 2026, 21:01 UTC

Pulse Biosciences Inc shares are lower in after-market hours, reflecting no specific news to explain the movement. The asset remains above its 20-day moving average.

7 ago 2026, 19:51 UTC

News

Pulse Biosciences shares are higher after reporting second-quarter revenue of $434,000 and increasing patient enrollment targets for its pivotal trial.

6 ago 2026, 22:16 UTC

News

Pulse Biosciences reported a net loss of $24.7 million for Q2 2026. Shares are trading higher after announcing significant progress in its cardiac catheter program.

5 ago 2026, 20:06 UTC

Pulse Biosciences Inc shares are lower during Wednesday's trading session, reversing from a recent trend of higher daily closes. No specific news was identified.

3 ago 2026, 20:03 UTC

Pulse Biosciences Inc shares are higher today, driven by a significant advance in the Health Care Equipment sector and unusually high trading volume.

31 jul 2026, 19:16 UTC

Pulse Biosciences Inc is gaining during Friday's session, reaching a high above Thursday's close. The stock remains above its 20-day moving average.

30 jul 2026, 20:09 UTC

Event

Pulse Biosciences' NANOPULSE-AF Study enrollment surpasses midpoint, supporting stock gains since Wednesday. Shares remain above the 20-day moving average amid market volatility.

29 jul 2026, 22:03 UTC

Event

Pulse Biosciences shares are lower in after-market hours despite surpassing enrollment midpoint in its NANOPULSE-AF Study, reflecting broader cautious market sentiment.

28 jul 2026, 23:46 UTC

Pulse Biosciences Inc shares are lower in after-market trading, reflecting volatility amid broader market declines, though no specific news was identified.

27 jul 2026, 19:51 UTC

Pulse Biosciences Inc shares are higher today amid unusually high trading volume, despite earlier downward movement. No specific news was identified to explain the move.

24 jul 2026, 18:11 UTC

Pulse Biosciences Inc shares are lower today, breaking a trend of higher daily closes. The stock is trading with unusually high market volume.

22 jul 2026, 19:31 UTC

Pulse Biosciences shares are higher today amid increased trading volume, despite earlier pulling back from session highs. No specific news was identified to explain the movement.

21 jul 2026, 22:51 UTC

Pulse Biosciences Inc shares declined in after-market trading, reversing earlier gains. No specific news was identified to explain the price movement.

20 jul 2026, 19:26 UTC

Shares of Pulse Biosciences Inc. are lower today, reversing earlier gains amid broader market pressure from rising US Treasury yields and geopolitical uncertainties.

Comparación entre iguales

Cambio de precio

Pulse Biosciences Inc previsión

Precio Objetivo

By TipRanks

-10.25% descenso

Estimación a 12 Meses

Media 45.25 USD  -10.25%

Máximo 58 USD

Mínimo 35 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pulse Biosciences Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

4

Comprar

0

Mantener

0

Vender

Sentimiento

By Acuity

299 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.